Apnimed secures $150 million financing to fuel US launch of oral sleep apnea drug AD109
The financing includes a four-year interest-only period, extendable to five years if a net sales milestone is achieved
The financing includes a four-year interest-only period, extendable to five years if a net sales milestone is achieved
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Now a test that offers new precision in prostate cancer detection
Marks first international filing for Evofem’s single-dose oral treatment
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
Akums Drugs will undertake this development and commercialization in India
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Subscribe To Our Newsletter & Stay Updated